Latest Innovation News

Chimeric Therapeutics' CHM CORE-NK cell therapy achieved a 60% complete response rate in high-risk frontline AML patients, significantly exceeding typical outcomes and maintaining a strong safety profile.

Brazilian Rare Earths (ASX: BRE) has reported substantial expansion of its Monte Alto rare earth project with ultra high-grade drilling results and validated low-temperature processing delivering 97% recovery. The company also secured a Trial Mining Licence enabling early production and bulk shipments.

Biome Australia has taken a significant step in its innovation journey by filing a patent for its next generation probiotic strain BMB18, with a clinical trial set to begin in Q4 FY26 in partnership with La Trobe University.

AdNeo (ASX:AD1) delivered its first positive operating cash flow quarter since its 2025 transformation, driven by strong revenue growth across all divisions and a growing $8m tender pipeline. The company advances its AI-first strategy while managing costs and acquisitions.

Noxopharm’s Sofra™ oligonucleotides, delivered via InhaTarget’s inhalable lipid nanoparticles, achieved a significant reduction in lung inflammation in preclinical models, broadening Sofra’s therapeutic reach and delivery versatility.

Stakk Ltd (ASX: SKK) has delivered a striking 272% jump in gross receipts to $5.36 million in Q3 FY26, reversing prior cash outflows with a positive net cash flow of $2.25 million and closing the quarter with $17.34 million in cash.

Ionic Rare Earths (ASX: IXR) has secured a £12 million UK government grant offer for its Belfast rare earth magnet recycling facility and is progressing its Brazilian JV and Ugandan heavy rare earths project, reinforcing its role in ex-China supply chains.

Saferoads Holdings maintained steady sales in the March quarter with a positive operating cash flow and ongoing product upgrades, despite cost pressures from oil-based materials and uncertainty over future orders from On-site Rentals.

Nickel Industries reported a reduced 2025 loss of US$41.2 million, bolstered by stable production, strategic debt refinancing, and progress on its flagship ENC HPAL project. Sustainability efforts and ore supply expansions set the stage for growth in 2026.

Lithium Universe Limited (ASX: LU7) is pushing ahead with its second lithium refinery in Texas and a silver recycling plant amid a strong lithium price rebound. The company secured a decade-long spodumene supply deal to underpin its flagship Canadian refinery and appointed Iggy Tan as full-time CEO to steer growth.

Noxopharm signed a strategic MoU with Tezcat Biosciences, published major Sofra RNA research, and appointed Dr Olivier Laczka as CEO, while reporting positive safety data from its HERACLES trial and improving cash flow.

Macallum New Energy has successfully listed on the ASX and raised A$7.4 million to fund exploration in the Northern Perth Basin. The company is progressing a 66% complete Barberton 3D seismic survey and preparing a Condor 2D survey, positioning itself amid renewed regional drilling activity.